Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Pancreatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02863367
What this trial is testing

A One-Arm Exploratory Clinical Trial of Apatinib Plus Gemcitabine in Patients With Advanced Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)UnknownNCT04151277
What this trial is testing

PRIMUS 001: A Study Looking at Two Different Chemotherapy Regimens in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Neoplasms Pancreatic
Judith Dixon-Hughes 500
Testing effectiveness (Phase 2)UnknownNCT04324307
What this trial is testing

Study of Immunotherapy Combined With Chemotherapy in Locally Advanced and Metastatic Pancreatic Cancer

Who this might be right for
Locally Advanced and Metastatic Pancreatic Cancer
Changhai Hospital 60
Not applicableLooking for participantsNCT05724992
What this trial is testing

Familial Pancreatic Cancer PROPHilation Program in Italy

Who this might be right for
Candidates for Hereditary Pancreatic Cancer Testing
Associazione Italiana per lo Studio del Pancreas 3,000
Not applicableStudy completedNCT04902144
What this trial is testing

Clinical Outcomes for Offering Genetic Testing in a Tiered Approach

Who this might be right for
Breast CarcinomaColon CarcinomaMalignant Solid Neoplasm+3 more
Fred Hutchinson Cancer Center 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06866977
What this trial is testing

A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Xiangya Hospital of Central South University 10
Not applicableStudy completedNCT00489671
What this trial is testing

Urine Cadmium Levels in Predicting Pancreatic Cancer Risk in Patients With Chronic Pancreatitis

Who this might be right for
Pancreatic CancerPrecancerous Condition
Wake Forest University Health Sciences 32
Not applicableLooking for participantsNCT06803771
What this trial is testing

Surveillance of Pancreatic Health After Diabetes Diagnosis

Who this might be right for
Diabetes MellitusPancreatic Cancer, Adult
University Hospital Southampton NHS Foundation Trust 15,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07469956
What this trial is testing

Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Resectable
Sun Yat-sen University 30
Not applicableUnknownNCT05595122
What this trial is testing

EUS-guided Choledochoduodenostomy for Primary Drainage of Malignant Distal Biliary Obstruction

Who this might be right for
Biliary ObstructionPancreas NeoplasmDistal Cholangiocarcinoma
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 25
Very early researchUnknownNCT05875753
What this trial is testing

68Ga-FAPI-FS PET/CT and PET/MR in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Peking Union Medical College Hospital 50
Not applicableUnknownNCT04274972
What this trial is testing

The Microbiome of Pancreatic Cancer: "PANDEMIC" Study

Who this might be right for
Microbial ColonizationPancreas CancerPancreas Infection+1 more
Azienda Ospedaliera Universitaria Integrata Verona 20
Early research (Phase 1)Study completedNCT02283372
What this trial is testing

Nab-Paclitaxel Plus Gemcitabine With Concurrent MR-Guided IMRT in Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Washington University School of Medicine 30
Testing effectiveness (Phase 2)Study completedNCT04524702
What this trial is testing

Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v8
Emory University 10
Early research (Phase 1)Study completedNCT04721301
What this trial is testing

Ipilimumab, Maraviroc and Nivolumab in Advanced Metastatic Colorectal and Pancreatic Cancer the LUMINESCENCE Trial

Who this might be right for
Colorectal Cancer MetastaticPancreatic Cancer Metastatic
University Hospital Heidelberg 50
Testing effectiveness (Phase 2)UnknownNCT03403101
What this trial is testing

The Combination Chemotherapy of SIRIOX as First- or Second-Line Chemotherapy for Pancreatic Cancer

Who this might be right for
Carcinoma, Pancreatic Ductal
Fudan University 65
Testing effectiveness (Phase 2)Ended earlyNCT01921751
What this trial is testing

High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery

Who this might be right for
Pancreatic AdenocarcinomaStage III Pancreatic Cancer
Radiation Therapy Oncology Group 20
Early research (Phase 1)Active Not RecruitingNCT03889795
What this trial is testing

Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors

Who this might be right for
Advanced Pancreatic CancerAdvanced Solid Tumor
Danae Hamouda, MD 15
Not applicableUnknownNCT06328101
What this trial is testing

Autoimmune Pancreatitis, Pancreatic and Extrapancreatic cAnceR (AiPPEAR)

Who this might be right for
Autoimmune Pancreatitis Type 1Autoimmune Pancreatitis Type 2
University Medical Center Goettingen 1,000
Early research (Phase 1)Looking for participantsNCT06182072
What this trial is testing

ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
ProDa BioTech, LLC 46
Next Page